Patent Application
Utility
Small
App. No. 14/690,981
· Confirmation No. 1023
Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity
Applicant:
SPROUT PHARMACEUTICALS, INC.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2016-05-05 | ABN |
Abandonment | 2 | View | |
| 2015-12-28 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2015-10-07 | CTNF |
Non-Final Rejection | 9 | View | |
| 2015-10-07 | 892 |
List of references cited by examiner | 1 | View | |
| 2015-10-07 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2015-10-07 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2015-10-07 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2015-09-29 | PD.FILED.E |
Priority Documents electronically retrieved by USPTO from a participating IP Office | 30 | View | |
| 2015-09-14 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-09-14 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2015-09-14 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2015-09-01 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2015-09-01 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2015-09-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2015-09-01 | 136A |
Authorization for Extension of Time all replies | 2 | View | |
| 2015-06-26 | PD.REQ.RETR |
Request for USPTO to retrieve priority docs | 2 | View | |
| 2015-06-26 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2015-05-01 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-05-01 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2015-05-01 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2015-05-01 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2015-04-20 | TRNA |
Transmittal of New Application | 2 | View | |
| 2015-04-20 | ADS |
Application Data Sheet | 7 | View | |
| 2015-04-20 | A.PE |
Preliminary Amendment | 1 | View | |
| 2015-04-20 | SPEC |
Specification | 1 | View | |
| 2015-04-20 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2015-04-20 | SPEC |
Specification | 22 | View | |
| 2015-04-20 | CLM |
Claims | 4 | View | |
| 2015-04-20 | ABST |
Abstract | 1 | View | |
| 2015-04-20 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2015-04-20 | WFEE |
Fee Worksheet (SB06) | 1 | View |
Inventors
Attorneys & Agents of Record
Classification
USPC
435/6
C07D235/26
A61P15/10
A61P43/00
A61P15/00
A61P29/00
Prosecution
- Examiner
- BERNHARDT, EMILY A
- Art Unit
- 1624
- Customer No.
- 21176
- Docket No.
- 9250.014US3
- Confirmation No.
- 1023
Foreign Priority
06126689.6
·
2006-12-20
·
EUROPEAN PATENT OFFICE (EPO)
Publication
- Pub. No.
- US20150368204A1
- Pub. Date
- 2015-12-24
Parent
is a Continuation of
→
App. 14/273,126
Filed 2014-05-08
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 12/518,574
· US 8,722,682
Filed 2010-10-04
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Parent
PCT
is a National Stage Entry of
→
PCT/EP2007/064120
Filed 2007-12-18
· Abandoned -- Failure to Respond to an Office Action
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
COMMONWEALTH LABORATORIES, LLC, AS GRANTOR,
SPROUT PHARMACEUTICALS, INC., AS GRANTOR,
SYNERGETICS USA, INC., AS GRANTOR,
UNILENS VISION INC., AS GRANTOR
SECURITY AGREEMENT
Recorded 2015-12-21
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 14/690,981
- Filed
- 2015-04-20
- Pub. No.
- US20150368204A1
- Examiner
- BERNHARDT, EMILY A
- Art Unit
- 1624
External Links